Pharmaceuticals

Adult Vaccines Market Future Analysis Covering Industry Shifts And Growth Potential

May 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Adult Vaccines Market Increase Between 2026 And 2030?

The adult vaccines market size has experienced robust growth in recent years. It is anticipated to expand from $24.21 billion in 2025 to $26.34 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion can be attributed to the rising prevalence of infectious diseases, government immunization initiatives, the development of novel vaccines, an increasing geriatric population, and improving healthcare infrastructure.

The adult vaccines market is forecast to experience robust expansion over the next few years. It is projected to reach $37.51 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be attributed to several factors such as advancements in mRNA and recombinant vaccine technologies, increased investment in adult immunization programs, the expansion of cold chain logistics, a growing awareness of vaccine-preventable diseases, and collaborations between pharmaceutical and biotechnology companies. Key trends anticipated in this period include heightened adult vaccination awareness, the broadening of immunization programs, the development of combination vaccines, an increase in vaccines for chronic disease management, and a rising demand for travel and occupational vaccines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Key Growth Drivers Are Influencing The Adult Vaccines Market?

The growth of the adult vaccine market was supported by elevated healthcare spending. Healthcare expenditure refers to the aggregate financial outlay for health services provided to a populace. A rise in healthcare expenditure frequently results in more substantial funding for medical research and development initiatives. By investing in immunization programs and broadening access to vaccines, healthcare systems can alleviate the burden of preventable illnesses and enhance overall population health. Furthermore, adult vaccination can lead to considerable cost savings by diminishing healthcare utilization and the necessity for expensive treatments. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based health company, Canada’s total health expenditure in 2023 is projected to reach $344 billion, which is an increase of over $9 billion compared to 2022. Therefore, the expanded healthcare spending favorably influenced the development of the adult vaccine market.

How Is Segment Classification Applied In The Adult Vaccines Market?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

What Trends Are Affecting The Adult Vaccines Market Dynamics?

Leading companies in the adult vaccines market are prioritizing the development of technological advancements, notably mRNA-based vaccines, to achieve rapid and precise immune response generation. This focus aims to address the increasing need for adult immunization against respiratory diseases. An mRNA vaccine operates by utilizing messenger RNA, encapsulated in lipid nanoparticles, to instruct human cells to produce specific viral proteins, thereby stimulating an immune response without employing live or attenuated viruses. For example, in May 2024, Moderna, a US-based biotechnology company, obtained FDA approval for mRESVI, which is an mRNA respiratory syncytial virus (RSV) vaccine intended for adults aged 60 years and older. This vaccine encodes the prefusion F glycoprotein of RSV and comes in single-dose, pre-filled syringes, facilitating neutralizing antibody production. It also offers improved safety and efficacy when compared to traditional inactivated or live-attenuated vaccines, consequently expanding adult immunization options.

Which Companies Are Influencing The Adult Vaccines Market?

Major companies operating in the adult vaccines market are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Access The Complete Adult Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Regional Market Leads The Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Adult Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Browse Through More Reports Similar to the Global Adult Vaccines Market 2026, By The Business Research Company

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795